| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
leucine rich repeat containing 10 | 0.861 | 0.115 | 0.43 |
|
group | 0.220 | None | 1.000 | 0 | 0 | 2017 | 2018 | ||||||||
|
leiomodin 2 | 0.805 | 0.154 | 5.5E-04 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
MAS related GPR family member D | 0.861 | 0.192 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2019 | 2019 | |||||||||
|
cytochrome c oxidase subunit 7A1 | 0.805 | 0.192 | 3.7E-05 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
T-box transcription factor 20 | 0.663 | 0.346 | 0.97 |
|
group | 0.220 | None | 1.000 | 0 | 0 | 2016 | 2017 | ||||||||
|
LIM domain binding 3 | 0.659 | 0.385 | 9.6E-06 |
|
group | 0.330 | None | 1.000 | 0 | 0 | 2004 | 2009 | ||||||||
|
troponin T2, cardiac type | 0.601 | 0.423 | 2.0E-03 |
|
group | 0.630 | None | 1.000 | 2 | 0 | 2000 | 2019 | ||||||||
|
cyclase associated actin cytoskeleton regulatory protein 2 | 0.716 | 0.423 | 0.70 |
|
group | 0.320 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
cathepsin V | 0.716 | 0.462 | 2.3E-07 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
tropomodulin 1 | 0.695 | 0.462 | 0.48 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
prospero homeobox 1 | 0.565 | 0.538 | 1.00 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
actin alpha cardiac muscle 1 | 0.610 | 0.538 | 0.74 |
|
group | 0.650 | None | 1.000 | 0 | 0 | 2006 | 2019 | ||||||||
|
sarcoglycan delta | 0.641 | 0.615 | 2.1E-03 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 1999 | 2018 | ||||||||
|
myosin heavy chain 6 | 0.581 | 0.615 | 1.6E-32 |
|
group | 0.620 | None | 1.000 | 1 | 0 | 2005 | 2015 | ||||||||
|
RAB1A, member RAS oncogene family | 0.623 | 0.615 | 0.82 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
myocardin | 0.619 | 0.615 | 0.33 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2003 | 2003 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
group | 0.700 | strong | 1.000 | 1 | 0 | 1998 | 2018 | ||||||||
|
centromere protein F | 0.601 | 0.654 | 1.9E-36 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
YME1 like 1 ATPase | 0.633 | 0.654 | 2.9E-02 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
polyhomeotic homolog 1 | 0.644 | 0.692 | 1.00 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
mediator complex subunit 1 | 0.573 | 0.692 | 1.00 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
nuclear receptor subfamily 2 group F member 2 | 0.575 | 0.692 | 0.99 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
cysteine and glycine rich protein 3 | 0.572 | 0.731 | 1.6E-04 |
|
group | 0.370 | None | 1.000 | 4 | 0 | 1997 | 2019 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
integrin linked kinase | 0.503 | 0.769 | 3.8E-05 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2007 | 2007 |